Hepatic cirrhosis, alcohol and haemorrhage

Insights

Investigating liver cirrhosis patients revealed that endoscopy is crucial for detecting esophageal varices and erosive lesions, as barium studies are insufficient. Gastric varices and portal hypertension require advanced imaging like radio-isotope scanning for accurate diagnosis.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Diagnostic Imaging

Background:

  • Cirrhosis of the liver is a significant health concern, often linked to heavy alcohol intake.
  • Gastrointestinal hemorrhage is a common complication in patients with liver cirrhosis.
  • Standard diagnostic methods like barium studies may underestimate the prevalence of esophageal varices and miss other significant lesions.

Purpose of the Study:

  • To evaluate the diagnostic utility of various imaging techniques in patients with cirrhosis and gastrointestinal bleeding.
  • To highlight the limitations of barium studies and standard endoscopy in detecting esophageal and gastric varices.
  • To assess the role of radio-isotope scanning in diagnosing cirrhosis and portal hypertension.

Main Methods:

  • Investigation of 50 consecutive patients with cirrhosis, including 29 with gastrointestinal hemorrhage.
  • Comparison of barium studies, fiber-endoscopy, gastrophotography, and radio-isotope scanning.
  • Assessment of spleen palpability in patients with portal hypertension.

Main Results:

  • Barium studies alone identified esophageal varices in only 40% of patients; erosive lesions were frequently observed.
  • Gastric varices were detected in 25% of patients with portal hypertension via gastrophotography but were difficult to identify with standard barium meal or endoscopy.
  • Radio-isotope scanning effectively supported the diagnosis of cirrhosis and portal hypertension, especially when the spleen was not palpable (detected in only 50% of patients).

Conclusions:

  • Fiber-endoscopy is essential for accurately diagnosing esophageal varices and erosive lesions in cirrhotic patients.
  • Gastric varices present a diagnostic challenge and may require specialized imaging techniques.
  • Radio-isotope scanning is a valuable tool for confirming cirrhosis and portal hypertension, particularly in cases with non-palpable spleens.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...